204 related articles for article (PubMed ID: 37455871)
21. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
22. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
23. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
24. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
26. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
[TBL] [Abstract][Full Text] [Related]
28. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
[TBL] [Abstract][Full Text] [Related]
29. The Price We Pay for Radical Curative Pelvic Exenterations: Prevalence and Management of Pain.
Lim JS; Koh CE; Liu H; Solomon MJ; Johnstone CSH
Dis Colon Rectum; 2018 Mar; 61(3):314-319. PubMed ID: 29420427
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
[TBL] [Abstract][Full Text] [Related]
31. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
33. Total pelvic exenteration for locally advanced rectal cancer.
Law WL; Chu KW; Choi HK
J Am Coll Surg; 2000 Jan; 190(1):78-83. PubMed ID: 10625236
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
35. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
[TBL] [Abstract][Full Text] [Related]
36. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
Yu JH; Tong CJ; Huang QD; Ye YL; Chen G; Li H; Wen YS; Yang F; Luo NB; Xu GY; Xiong Y
BMC Cancer; 2024 Jan; 24(1):88. PubMed ID: 38229045
[TBL] [Abstract][Full Text] [Related]
38. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
[TBL] [Abstract][Full Text] [Related]
39. Pelvic exenterations combined with cytoreductions for T4 rectal cancers with peritoneal metastasis: a safety analysis.
Kazi M; Raghavan S; Desouza A; Saklani A
ANZ J Surg; 2024 Apr; 94(4):702-707. PubMed ID: 38012077
[TBL] [Abstract][Full Text] [Related]
40. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
